States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand
Executive Summary
US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.
You may also be interested in...
States With Age Restriction On OTC DXM Sales Number 17 – And Counting
Pennsylvania is 17th US state to limit sales of dextromethorphan OTCs to consumers 18 and older because teenagers' abuse of the ingredient for intoxicating effect remains a common problem.
States With Age Restriction On OTC DXM Sales Number 17 – And Counting
Pennsylvania is 17th US state to limit sales of dextromethorphan OTCs to consumers 18 and older because teenagers' abuse of the ingredient for intoxicating effect remains a common problem.
Perrigo Recalls Tamper-Resistant PSE Product Due To Contamination
FDA on Dec. 21 identified the recall as class II, for violative products that may cause temporary or medically reversible adverse health consequences though the probability of serious consequences is remote. Perrigo acquired the Zephrex-D brand and rights to the formulation in 2016.